Nuzenio

Ycanth

Ycanth news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Verrica Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 19:04:20 GMTChester County firm secures up to $27.5M loan from chairman, largest shareholder - The Business JournalsThe Business Journals · Fri, 07 Aug 2026 16:59:00 GMTVerrica: Buy Rating Reiterated on YCANTH Momentum, Pivotal Wart Program Progress, and Strengthened Balance Sheet; $12 Price Target Maintained - TipRanksTipRanks · Fri, 07 Aug 2026 13:41:05 GMTStacy Ku Reiterates Buy on Verrica as Ycanth’s Strong Uptake and Wart Expansion Opportunity Support Long-Term Growth - TipRanksTipRanks · Fri, 07 Aug 2026 11:28:03 GMTVerrica lands $27.5M debt facility from its chairman to fund YCANTH growth - DealroomDealroom · Thu, 06 Aug 2026 21:11:11 GMTVerrica Pharmaceuticals reports Q2 2026 revenue $5.9M, net loss $13.2M; YCANTH demand up - TradingViewTradingView · Thu, 06 Aug 2026 20:37:10 GMTVerrica Pharmaceuticals Reports Second Quarter 2026 Financial Results - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:15:03 GMTVerrica Pharmaceuticals Closes Credit Facility For Up To $27.5 Million in Non-Dilutive Growth Capital - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:14:05 GMT

Timeline

Fri, 07 Aug 2026 19:04:20 GMTVerrica Pharmaceuticals Q2 Earnings Call Highlights - TradingView
Fri, 07 Aug 2026 16:59:00 GMTChester County firm secures up to $27.5M loan from chairman, largest shareholder - The Business Journals
Fri, 07 Aug 2026 13:41:05 GMTVerrica: Buy Rating Reiterated on YCANTH Momentum, Pivotal Wart Program Progress, and Strengthened Balance Sheet; $12 Price Target Maintained - TipRanks
Fri, 07 Aug 2026 11:28:03 GMTStacy Ku Reiterates Buy on Verrica as Ycanth’s Strong Uptake and Wart Expansion Opportunity Support Long-Term Growth - TipRanks
Thu, 06 Aug 2026 21:11:11 GMTVerrica lands $27.5M debt facility from its chairman to fund YCANTH growth - Dealroom
Thu, 06 Aug 2026 20:37:10 GMTVerrica Pharmaceuticals reports Q2 2026 revenue $5.9M, net loss $13.2M; YCANTH demand up - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ycanth.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.